首页> 外文OA文献 >Axitinib as a third or further line of treatment in renal cancer. A single institution experience

【2h】

Axitinib as a third or further line of treatment in renal cancer. A single institution experience

机译：Axitinib作为肾癌中的第三种或进一步的治疗方法。单一机构经验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Giorgos Tsironis; Michalis Liontos; ANASTASIOS KYRIAZOGLOU; Konstantinos Koutsoukos; Anna Tsiara; Maria Kaparelou; Roubini Zakopoulou; Abis Cohen; Efi Skafida; Sofia Fontara; Flora Zagouri; Aristotelis Bamias; Meletios Athanasios Dimopoulos;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. 肾脏肿瘤保留肾单位手术的评价:单一机构的经验 [J] . Hytham Abd-elkareem Ahmed, Abdelhamid Hussein Ezzat, Ismael Mourad 中德临床肿瘤学杂志（英文版） . 2011,第009期
2. Axitinib as a third or further line of treatment in renal cancer: a single institution experience [J] . G. Tsironis, M. Liontos, A. Kyriazoglou, BMC Urology . 2020,第1期

机译：Axitinib作为肾癌中的第三种或进一步的治疗方法：单一机构经验
3. Feasibly of axitinib as first-line therapy for advanced or metastatic renal cell carcinoma: a single-institution experience in Japan [J] . Takuya Koie, Chikara Ohyama, Takahiro Yoneyama, BMC Urology . 2015,第1期

机译：将阿西替尼作为晚期或转移性肾细胞癌的一线治疗的可行性：在日本的单机构经验
4. Mastectomy patterns, but not rates, are changing in the treatment of early breast cancer. Experience of a single European institution on 2315 consecutive patients [J] . Fancellu Alessandro, Sanna Valeria, Cottu Pietrina, The Breast : . 2018,第期

机译：乳房切除术模式，但不是率，正在改变早期乳腺癌的治疗。连续2315名欧洲机构的经验
5. HIGH DOSE MELPHALAN AND AUTOLOGOUS STEM CELL TRANSPLANTATION (HDM/SCT) FOR TREATMENT OF AL AMYLOIDOSIS: TEN YEAR SINGLE INSTITUTIONAL EXPERIENCE [C] . D. C. Setdin, V. Sanchorawala, K. Malek, International Symposium on Amyloidosis . 2005

机译：高剂量素母蛋白和自体干细胞移植（HDM / SCT）用于治疗Al淀粉样症：十年单一制度经验
6. From 'sex toy' to intrusive imposition: A qualitative examination of women's experiences with vaginal dilator use following treatment for gynecological cancer. [D] . Cullen, Kimberley-Anne S. 2011

机译：从“性玩具”到强加性行为：对妇科癌症治疗后妇女使用阴道扩张器的经历进行定性检查。
7. Axitinib as a third or further line of treatment in renal cancer: a single institution experience [O] . G. Tsironis, M. Liontos, A. Kyriazoglou, 2020

机译：阿昔替尼作为肾癌的第三或其他治疗方案：单一机构经验
8. Feasibly of axitinib as first-line therapy for advanced or metastatic renal cell carcinoma: a single-institution experience in Japan [O] . Takuya Koie, Chikara Ohyama, Takahiro Yoneyama, 2015

机译：将阿西替尼作为晚期或转移性肾细胞癌的一线治疗的可行性：在日本的单机构经验

Axitinib as a third or further line of treatment in renal cancer. A single institution experience

著录项

引文网络

相似文献

相关主题

期刊订阅